Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy has become one of the most prescribed weight loss medications in America, but many patients don't fully understand what's inside the pen or how it actually works at a cellular level. The active ingredient is semaglutide, a synthetic copy of a natural hormone your gut produces after eating. When injected weekly, semaglutide triggers a cascade of signals in your brain and digestive system that reshape how you experience hunger and fullness.
What Is Semaglutide and How Does It Work?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist—a class of medications that mimic your body's natural GLP-1 hormone. This hormone is released from cells in your small intestine after you eat, and it plays a central role in regulating blood sugar, appetite, and how fast your stomach empties food. When you inject semaglutide, it binds to GLP-1 receptors located in your brain's appetite control centers, primarily in the hypothalamus, triggering a strong signal of satiety even when you've eaten less food than usual.
Beyond appetite suppression, semaglutide slows gastric motility, meaning food stays in your stomach longer and you feel fuller for extended periods. Studies show that patients on semaglutide consume approximately 500–800 fewer calories per day without consciously restricting intake. The medication also improves insulin sensitivity and can help stabilize blood sugar levels, which is why GLP-1 agonists were first developed for type 2 diabetes management before their weight loss benefits became widely recognized.
Complete List of Wegovy Injection Ingredients and Excipients
Each Wegovy pen contains semaglutide as the active pharmaceutical ingredient, but the formulation also includes several inactive ingredients—called excipients—that ensure stability, sterility, and proper delivery. The excipients in Wegovy are sodium phosphate dibasic dihydrate, sodium phosphate monobasic dihydrate, sodium chloride, and water for injection. These buffer systems maintain the pH of the solution so the medication remains stable and safe for subcutaneous injection over time.
Wegovy pens are filled with 1.5 mL of solution containing either 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, or 2.4 mg of semaglutide depending on the dose strength—though all are supplied as 2.4 mL pens with adjustable dial mechanisms. The injectable form must be preservative-free and pyrogen-free to meet medical standards for intradermal and subcutaneous use. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies that follow identical pharmaceutical standards and use the same buffer systems and excipient profiles.
Why Compounded Semaglutide Costs Less Than Wegovy Brand Name
Novo Nordisk, the manufacturer of brand-name Wegovy, sets the wholesale price around $969 per pen, and retail prices often exceed $1,400 before insurance or patient assistance programs. This premium reflects decades of research and development, clinical trials, FDA regulatory approval processes, marketing expenses, and patent protections. Once a medication's patent nears expiration or when regulatory pathways allow compounding, licensed 503A pharmacies can legally prepare the same active ingredient at a fraction of the cost by eliminating redundant development and marketing expenses.
PlexusDx compounded semaglutide injections start at $149 per month—a price point made possible because 503A compounding pharmacies prepare doses in smaller batches without the overhead of maintaining brand manufacturing facilities and global distribution networks. The active pharmaceutical ingredient (semaglutide) is identical; the excipients and pharmaceutical standards are equivalent; and the therapeutic outcome is the same. Your dose may need to go up as your treatment progresses, but your price won't—PlexusDx offers one flat monthly rate regardless of dose level.
Clinical Evidence: How Semaglutide Produces Weight Loss Results
The landmark STEP trials (Semaglutide Treatment Effect in People with Obesity) enrolled over 4,500 adults with obesity or overweight with weight-related conditions. In STEP 1, participants on semaglutide 2.4 mg weekly achieved average weight loss of 15.3 kg (33.7 lbs) over 68 weeks compared to 2.6 kg (5.7 lbs) in placebo—a 70% reduction in body weight compared to control. These results emerged not from appetite suppression alone but from coordinated changes in hunger hormones, improved insulin sensitivity, reduced cravings for high-calorie foods, and shifts in how the brain perceives reward from eating.
Imaging studies using positron emission tomography (PET) show that semaglutide increases activity in brain regions associated with satiety and decreases activity in areas linked to food craving and reward anticipation. Over 12 months, approximately 80% of semaglutide users experience clinically meaningful weight loss (≥5% body weight reduction), and many sustain that loss or continue losing additional weight as long as they remain on treatment. PlexusDx patients can access this same evidence-based mechanism through compounded semaglutide at significantly lower cost.
Understanding Your Body's Peptide Response With Precision Genetic Testing
Not all bodies respond to semaglutide with equal intensity—genetic variations in your GLP-1 receptor and related peptide pathways can predict how well you'll tolerate the medication and how robust your weight loss response will be. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These variants influence how efficiently your GLP-1 receptors function, how responsive your appetite center is to semaglutide signaling, and your intrinsic metabolic set point.
The Precision Peptide Genetic Test maps 14 metabolic pathways, 49 distinct peptides, and 150+ genetic insights specific to weight regulation and GLP-1 responsiveness. Understanding your genetic profile allows PlexusDx clinicians to predict whether you'll thrive on semaglutide monotherapy, whether you might benefit from dual-compound formulations like GLP-Squared (semaglutide plus tirzepatide), or whether alternative dosing strategies could optimize your results. This personalization transforms weight loss from a one-size-fits-all approach into a precision medicine strategy tailored to your biological blueprint.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide the exact same thing as Wegovy?
Yes, the active ingredient (semaglutide) is identical. Both are produced to pharmaceutical standards from licensed facilities. The key difference is cost: PlexusDx compounded semaglutide starts at $149/month versus $1,400+ for brand Wegovy. Your dose may increase over time, but your price stays the same.
How long does semaglutide stay in your system after injection?
Semaglutide has a half-life of approximately 7 days, meaning half the injected dose is still active one week after injection. This extended duration allows for convenient once-weekly dosing. Peak concentrations occur 1–3 days after injection, and most patients feel the appetite-suppressing effects within 2–4 hours of administration.
Does PlexusDx require insurance or membership to access semaglutide?
No. PlexusDx serves all 50 states with no insurance requirement and no membership fees. Compounded semaglutide injections start at $149/month and are HSA/FSA eligible. All medications are shipped directly from licensed 503A compounding pharmacies.
What are the most common side effects of semaglutide injections?
The most frequent side effects are nausea, vomiting, and diarrhea—typically occurring in the first 2–4 weeks as your body adjusts. Most patients report that side effects diminish with time. Serious side effects are rare but can include pancreatitis or gallbladder issues; always report severe symptoms to your prescribing clinician immediately.
How does the Precision Peptide Genetic Test help optimize my semaglutide treatment?
The test identifies genetic variants in your GLP-1 receptor and related metabolic pathways that predict medication response and tolerance. This insight helps PlexusDx clinicians determine whether you'll achieve optimal results on semaglutide alone or whether you might benefit from alternative formulations or dosing strategies, maximizing your personalized outcome.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Accelerate Weight Loss on Mounjaro: Tips for Success
How to Do an Ozempic Injection: A Comprehensive Guide